WallStreetZenWallStreetZen

NYSEMKT: STXS
Stereotaxis Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their STXS stock forecasts and price targets.

Forecast return on equity

Is STXS forecast to generate an efficient return?

Company
-158.77%
Industry
20.17%
Market
268.35%
STXS's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is STXS forecast to generate an efficient return on assets?

Company
-5.61%
Industry
14.98%
STXS is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

STXS earnings per share forecast

What is STXS's earnings per share in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
-$0.24
Avg 2 year Forecast
-$0.18
Avg 3 year Forecast
-$0.03

STXS revenue forecast

What is STXS's revenue in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
$35.3M+10.85%
Avg 2 year Forecast
$52.8M+66.12%
Avg 3 year Forecast
$81.6M+156.56%
STXS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

STXS revenue growth forecast

How is STXS forecast to perform vs Medical Instruments & Supplies companies and vs the US market?

Company
32.92%
Industry
7.83%
Market
58.52%
STXS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
STXS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

STXS vs Medical Stocks

TickerPricePrice TargetUp/downsideConsensus
STXS$2.92N/AN/A
SMTI$28.81$54.00+87.43%Buy
INFU$10.00$13.50+35.00%Strong Buy
OSUR$2.70$3.00+11.11%Hold
NYXH$5.03N/AN/A
View Top Medical Stocks

Stereotaxis Stock Forecast FAQ

What is STXS's earnings growth forecast for 2025-2027?

(NYSEMKT: STXS) Stereotaxis's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Instruments & Supplies industry's average forecast earnings growth rate of 23.76%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 102.26%.

Stereotaxis's earnings in 2025 is -$24,638,000.On average, 6 Wall Street analysts forecast STXS's earnings for 2025 to be -$21,729,708, with the lowest STXS earnings forecast at -$22,210,173, and the highest STXS earnings forecast at -$19,989,156. On average, 6 Wall Street analysts forecast STXS's earnings for 2026 to be -$16,417,398, with the lowest STXS earnings forecast at -$21,321,766, and the highest STXS earnings forecast at -$8,566,781.

In 2027, STXS is forecast to generate -$2,311,671 in earnings, with the lowest earnings forecast at -$3,553,628 and the highest earnings forecast at -$951,865.

If you're new to stock investing, here's how to buy Stereotaxis stock.

What is STXS's revenue growth forecast for 2025-2027?

(NYSEMKT: STXS) Stereotaxis's forecast annual revenue growth rate of 32.92% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 7.83%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 58.52%.

Stereotaxis's revenue in 2025 is $31,806,000.On average, 5 Wall Street analysts forecast STXS's revenue for 2025 to be $3,196,270,587, with the lowest STXS revenue forecast at $2,967,279,167, and the highest STXS revenue forecast at $3,360,081,948. On average, 5 Wall Street analysts forecast STXS's revenue for 2026 to be $4,789,782,539, with the lowest STXS revenue forecast at $3,749,077,271, and the highest STXS revenue forecast at $5,473,221,303.

In 2027, STXS is forecast to generate $7,397,347,550 in revenue, with the lowest revenue forecast at $7,107,255,490 and the highest revenue forecast at $7,614,916,596.

What is STXS's forecast return on assets (ROA) for 2025-2027?

(NYSEMKT: STXS) forecast ROA is -5.61%, which is lower than the forecast US Medical Instruments & Supplies industry average of 14.98%.

What is STXS's Earnings Per Share (EPS) forecast for 2025-2027?

(NYSEMKT: STXS) Stereotaxis's current Earnings Per Share (EPS) is -$0.29. On average, analysts forecast that STXS's EPS will be -$0.24 for 2025, with the lowest EPS forecast at -$0.25, and the highest EPS forecast at -$0.22. On average, analysts forecast that STXS's EPS will be -$0.18 for 2026, with the lowest EPS forecast at -$0.24, and the highest EPS forecast at -$0.09. In 2027, STXS's EPS is forecast to hit -$0.03 (min: -$0.04, max: -$0.01).

What is STXS's forecast return on equity (ROE) for 2025-2027?

(NYSEMKT: STXS) forecast ROE is -158.77%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.